Be sure to check our sister interview main ratings news website

AVCT

Hardman & Co

Avacta Group Plc Change in R&D accounting policy

2nd August 2016

Avacta Group Plc (LON:AVCT) is a life science company providing high quality and highly specific tools to the biopharmaceutical industry to help in the diagnosis and treatment of humans and

Q&As

Cerillion

Cerillion’s Louis Hall on FY results, market potential and future outlook (LON:CER)

Ilika plc

Ilika CEO highlights growth, Cirtec partnership and market opportunities (LON:IKA)

Dekel Agri-Vision PLC

Dekel Agri-Vision’s Lincoln Moore on cashew growth and 2025 goals

Touchstone Exploration

Touchstone Exploration CEO on Cascadura results, Rio Claro block and 2025 plans (LON:TXP)

Hardman & Co

ICG Enterprise Trust: Strong portfolio growth, increased investments and resilient strategy

Firering Strategic MineralS PLC

Firering Strategic Minerals targets Q4 commissioning and Limeco expansion (LON:FRG)

Funds

Fidelity Special Values

UK stocks rally as market confidence rebounds

Fidelity Japan Trust

Nikkei index surges amid renewed optimism

Fidelity European Trust

European markets open strong as optimism rises

Fidelity Asian Values

Markets rally as optimism grows amid Treasury appointment

Fidelity Emerging Markets

Positive momentum for Emerging Markets as US dollar weakens

JPMorgan European Discovery Trust

European markets begin the week on a positive note

Presentations

Ilika plc

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance plc

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Pulsar Helium Inc

Pulsar Helium Inc.: A Pioneering Force in the Helium Industry with High-Concentration Discoveries

Pennant International plc

Pennant International Maximising operational efficiency

Norcros Plc

Norcros Results Year ended 31 March 2024, Strategic Success and Sustainable Growth

SAE Renewables

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

Broker Talk

Norcros Plc

Norcros plc Strategic Resilience and Growth in Challenging Markets

Hardman & Co

Duke Capital: Unlocking growth with strategic equity raise

Hardman & Co

Volta Finance: Robust returns and discounted value highlight investment opportunity

Hardman & Co

Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25

Hardman & Co

City of London Investment Company sees positive growth in Q4 and FY24 FUM

Hardman & Co

Expertise and strategic asset management in an under-supplied market

© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.